Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation

计划入组 17 人 · 首次发布于 2016 年 10 月 13 日

Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers

计划入组 10 人 · 首次发布于 2010 年 3 月 11 日

Statistical Parametric Mapping (SPM 1D) for Stroke and Trans-tibial Amputation

计划入组 30 人 · 首次发布于 2019 年 11 月 20 日

Naratriptan

C₁₇H₂₅N₃O₂S

Almotriptan(Axert)

C₁₇H₂₅N₃O₂S

Frovatriptan(Frova)

C₁₄H₁₇N₃O

Center 5

United States

Hangzhou MTR Line 5 Corporation Limited

China

INVESCO LDRRITE US 0-5 YR CO BD IDX CAD UNITS

FDA Accepts Axsome's NDA Resubmission for AXS-07 in Acute Migraine Treatment

Akums Launches World's First Lasmiditan Dispersible Tablets for Acute Migraine Treatment

FDA Approves Axsome's Symbravo (Meloxicam and Rizatriptan) for Acute Migraine Treatment